ES443825A1 - Procedimiento para la preparacion de d-homoroceto-pregna- nos. - Google Patents

Procedimiento para la preparacion de d-homoroceto-pregna- nos.

Info

Publication number
ES443825A1
ES443825A1 ES443825A ES443825A ES443825A1 ES 443825 A1 ES443825 A1 ES 443825A1 ES 443825 A ES443825 A ES 443825A ES 443825 A ES443825 A ES 443825A ES 443825 A1 ES443825 A1 ES 443825A1
Authority
ES
Spain
Prior art keywords
hydrogen
ketopregnanes
homo
image
narcosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443825A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742461312 external-priority patent/DE2461312A1/de
Priority claimed from DE19752506688 external-priority patent/DE2506688A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES443825A1 publication Critical patent/ES443825A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES443825A 1974-12-23 1975-12-23 Procedimiento para la preparacion de d-homoroceto-pregna- nos. Expired ES443825A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19742461312 DE2461312A1 (de) 1974-12-23 1974-12-23 D-homo-20-keto-pregnane und verfahren zu ihrer herstellung
DE19752506688 DE2506688A1 (de) 1975-02-14 1975-02-14 D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES443825A1 true ES443825A1 (es) 1977-05-01

Family

ID=25768157

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443825A Expired ES443825A1 (es) 1974-12-23 1975-12-23 Procedimiento para la preparacion de d-homoroceto-pregna- nos.

Country Status (13)

Country Link
US (1) US4056633A (enExample)
JP (1) JPS5188953A (enExample)
AU (1) AU501685B2 (enExample)
CA (1) CA1051868A (enExample)
DD (1) DD123329A5 (enExample)
DK (1) DK138501C (enExample)
ES (1) ES443825A1 (enExample)
FR (1) FR2295739A1 (enExample)
GB (1) GB1538869A (enExample)
IL (1) IL48628A0 (enExample)
LU (1) LU74087A1 (enExample)
NL (1) NL7514976A (enExample)
SE (1) SE7514514L (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104306A (en) * 1976-05-05 1978-08-01 Abbott Laboratories 12A-Deoxy chelocardin
US5439900A (en) * 1993-02-25 1995-08-08 Bukusoglu; Cuneyt Methods and compositions for providing analgesia and enhanced anesthesia
ATE339437T1 (de) * 2002-08-16 2006-10-15 Pharmacia & Upjohn Co Llc 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
TR201901745T4 (tr) 2013-04-17 2019-03-21 Sage Therapeutics Inc 19-nor C3,3-disübstitüe edilmiş C21- n-pirazolil steroidleri ve bunların kullanım yöntemleri.
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
EP2986624B1 (en) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
RU2754534C2 (ru) 2013-07-19 2021-09-03 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, композиции и их использование
CA3235088A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
TW202426002A (zh) 2014-10-16 2024-07-01 美商賽吉醫療公司 用於治療中樞神經系統(cns)病症之組合物及方法
EP3753927B1 (en) 2014-10-16 2023-07-19 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3224269T (lt) 2014-11-27 2020-07-10 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
HUE054092T2 (hu) 2015-01-26 2021-08-30 Sage Therapeutics Inc Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481845T3 (da) 2016-07-11 2023-11-27 Sage Therapeutics Inc C17, c20 og c21 substituerede neuroaktive steroider og deres anvendelsesmetoder
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
AU2018392093B2 (en) * 2017-12-22 2024-02-01 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
JP7538040B2 (ja) * 2018-01-12 2024-08-21 セージ セラピューティクス, インコーポレイテッド CNS障害の処置における使用のためのアザ、オキサ、およびチア-プレグナン-20-オン-3α-オール化合物
JP7539378B2 (ja) 2018-12-05 2024-08-23 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその使用方法
BR112021013393A2 (pt) * 2019-01-08 2021-09-14 Chengdu Kanghong Pharmaceutical Co, Ltd. Composto de esteroide e uso do mesmo e método de preparação para o mesmo
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders
EP3990467A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876705A (en) * 1972-06-12 1975-04-08 Univ New Brunswick Steroid total synthesis and intermediates

Also Published As

Publication number Publication date
DK138501C (da) 1979-02-19
FR2295739A1 (fr) 1976-07-23
DK588775A (da) 1976-06-24
GB1538869A (en) 1979-01-24
US4056633A (en) 1977-11-01
LU74087A1 (enExample) 1976-07-20
JPS5188953A (en) 1976-08-04
NL7514976A (nl) 1976-06-25
DD123329A5 (enExample) 1976-12-12
CA1051868A (en) 1979-04-03
AU8763775A (en) 1977-06-23
IL48628A0 (en) 1976-02-29
AU501685B2 (en) 1979-06-28
DK138501B (da) 1978-09-18
SE7514514L (sv) 1976-06-24

Similar Documents

Publication Publication Date Title
ES443825A1 (es) Procedimiento para la preparacion de d-homoroceto-pregna- nos.
ES455804A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
ES455149A1 (es) Procedimiento para preparar n-fenil-n'-benzoil-ureas.
ES471803A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES433145A1 (es) Procedimiento para preparar derivados de fenoxipropilamina.
ES475241A1 (es) Procedimiento para combatir microorganismos en materiales organicos o inorganicos y proteger estos materiales contra el ataque de aquellos
GB2191196B (en) Imidazo pyrimidines
GR82123B (enExample)
ES457385A1 (es) Procedimiento para preparar derivados de prostaglandinas.
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
ES464728A1 (es) Procedimiento para producir derivados del acido propionico
ES440395A1 (es) Procedimiento para la produccion de esteres de acidos piri- midiniltionofosfonicos.
ES443692A1 (es) Procedimiento para la obtencion de 3-fluorbenzodiazepinas.
ES476166A1 (es) Procedimiento para la preparacion de nuevas imidazo-isoqui- nolein-dionas
ES439038A1 (es) Procedimiento para la preparacion de nuevas isoquinoleinas.
ES443536A1 (es) Procedimiento para la obtencion de composiciones herbicidas.
ES435622A1 (es) Procedimiento para la preparacion de bencenosulfonifurcas.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
ES459197A1 (es) Procedimiento para preparar esteres oximicos de isonitroso- cianoacetamida.
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES448989A1 (es) Procedimiento para la obtencion de derivados alquinicos.
ES438513A1 (es) Procedimiento para la obtencion de derivados de hexahidro- diazepino-indol.
ES445543A1 (es) Un procedimiento para la preparacion de amino-esteres de acidos benzoil-alcanoicos.
ES441437A1 (es) Procedimiento para la preparacion de crotonanilidas susti- tuidas.